Karyopharm(KPTI)

7.27 -0.43 -5.5844%

今开:7.51昨收:7.7
最高:7.66 最低:7.04
涨停价:0.0跌停价:0.0
总市值:5.4923031E8

Karyopharm的最新评论

北美剑客2020-03-31 01:23

$Karyopharm(KPTI)$ :美股小票套利条件: 1.风口; 2交易额大,便于进出; 3.必须不破波段线,即在波段线上运行。 4.近期存在催化剂预期。 可关注: PSTV:公司两种癌症候选药物,1.32亿里程碑付款,在二季度完成,机构建仓柱后回调地量跟进。 OMI:疫情受益股,今年扭亏盈利。 SPCB:冠状病毒检测设...查看全文

Karyopharm(KPTI)2020-03-18 05:40

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-019703 Size: 5 KB 网页链接查看全文

Karyopharm(KPTI)2020-03-18 05:30

$Karyopharm(KPTI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-019694 Size: 7 KB 网页链接查看全文

Karyopharm(KPTI)2020-03-14 04:25

$Karyopharm(KPTI)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-20-072904 Act: 33 Size: 85 KB 网页链接查看全文

Karyopharm(KPTI)2020-03-12 08:45

$Karyopharm(KPTI)$ 内部交易: 2020-03-10,CEO,Kauffman Michael ,卖出,10000普通股, $22.22查看全文

Karyopharm(KPTI)2020-03-12 08:45

$Karyopharm(KPTI)$ 内部交易: 2020-03-09,CEO,Kauffman Michael ,卖出,10000普通股, $22.52查看全文

Karyopharm(KPTI)2020-03-12 08:45

$Karyopharm(KPTI)$ 内部交易: 2020-03-09,CEO,Kauffman Michael ,期权,10000普通股, $4.75查看全文

Karyopharm(KPTI)2020-03-12 08:45

$Karyopharm(KPTI)$ 内部交易: 2020-03-10,CEO,Kauffman Michael ,期权,10000普通股, $4.75查看全文

Karyopharm(KPTI)2020-03-12 08:45

$Karyopharm(KPTI)$ 内部交易: 2020-03-10,总裁 & CSO,Shacham Sharon ,卖出,10000普通股, $22.22查看全文

Karyopharm(KPTI)2020-03-12 08:45

$Karyopharm(KPTI)$ 内部交易: 2020-03-09,总裁 & CSO,Shacham Sharon ,卖出,10000普通股, $22.52查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49

Karyopharm的公告

季度财报

$Karyopharm(KPTI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-21-002729 Act: 34 Size: 9 MB 网页链接

当期报告

$Karyopharm(KPTI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-21-317648 Act: 34 Size: 274 KB 网页链接

超过5%股东持股披露「修订」

$Karyopharm(KPTI)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000093751-21-000679 Act: 34 Size: 10 KB 网页链接

员工持股计划

$Karyopharm(KPTI)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-21-237892 Act: 33 Size: 93 KB 网页链接

其他

$Karyopharm(KPTI)$ S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers Accession Number: 0001193125-21-237843 Act: 33 Size: 222 KB 网页链接

季度财报

$Karyopharm(KPTI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-21-000948 Act: 34 Size: 9 MB 网页链接

当期报告

$Karyopharm(KPTI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-21-236958 Act: 34 Size: 292 KB 网页链接

持股变动声明

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-046589 Size: 4 KB 网页链接

当期报告

$Karyopharm(KPTI)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001193125-21-197924 Act: 34 Size: 244 KB 网页链接

$Karyopharm(KPTI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-21-039816 Size: 7 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78